Urine testing for risk of prostate cancer: a current and future perspective

It is becoming very clear that over the next 5 to 10 years we will develop a whole new spectrum of urine-based tests for the assessment of risk for prostate cancer and whether a specific patient will actually need a biopsy and/or other tests to confirm diagnosis. … READ MORE…

The APCCC in Basel, Switzerland: Day 2

The second day of the APCCC here in Basel ran for 10 hours and encompassed a total of six sessions, as follows: … READ MORE …

Speed of change in the management of prostate cancer

One of our regular correspondents (who lives in England) was recently told something rather interesting by the Consultant Urologist he sees in the UK. … READ MORE …

Two leading women talk about the future of treatment of advanced prostate cancer

Nearly 30 years ago, when your sitemaster first attended a prostate cancer meeting (in 1989) related to the upcoming approval of a new drug called flutamide, he doesn’t remember there being a single clinician at the meeting who was female — out of the 150 or so urologists and medical oncologists who had been invited. … READ MORE …

OMG … as if it wasn’t bad enough to have the acne in the first place … !

Just in case most of our readers are so old that they have forgotten … severe acne is one of the traumatizing events of male (and female) adolescence. I mean, “Duh. Whose gonna wanna to date me when … READ MORE …

Recommendations of the Prostate Cancer Clinical Trials Working Group 3

Several readers will be interested in looking through a new article that deals with the recommendations from the Prostate Cancer Clinical Trials Working Group 3 on the development of clinical trials of new drugs to treat castration-resistant prostate cancer (CRPC). … READ MORE …

“Cyborgs in the battle against prostate cancer”

Well … apparently a number of the readers of this web site may have sci-fi personas in their future. We won’t spoil the fun in this one: just click here!

Intense discussion of the future of focal therapy in prostate cancer

At a 4-hour meeting yesterday afternoon here in New Orleans there was intense discussion of issues related to the future of focal therapy and (potentially) to the approval of new types of device and technologies that might be able to deliver focal therapy. … READ MORE …

New technology, over-treatment (it ain’t just a prostate cancer issue), and PCORI

We are probably all aware that the “commercialization” of medicine in the past 30+ years — in association with the development of new technologies that may (or may not) actually improve outcomes for individual patients — has driven up medical costs. Many hospitals and doctors want to generate revenue (and profits); so do most developers of new drugs and devices. … READ MORE …

What will be the global incidence of prostate cancer by 2030?

According to a new set of projections just published in The Lancet this morning, the total global burden of new cases of cancer will increase by about 75 percent (from 12.7 million in 2008 to 22.2 million in 2030) over the next 30-odd years. … READ MORE …

It’s time to bury annual, mass, population-based prostate cancer screening

For nearly 20 years America has conducted a massive experiment based on an unproven hypothesis … that we could significantly reduce prostate cancer mortality rates if we gave every man over 50 a PSA test and a physical examination (using a DRE) every single year. But it’s not true, …  and it’s time to face up to that reality. … READ MORE …